244 related articles for article (PubMed ID: 200320)
1. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
Gerber JD; Marron AE; Bass EP; Beckenhauer WH
Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of pregnant ponies against equine rhinopneumonitis.
Crandell RA; Mock RE; Lock TF
Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
[TBL] [Abstract][Full Text] [Related]
3. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
Bryans JT
Am J Vet Res; 1980 Nov; 41(11):1743-6. PubMed ID: 6259970
[TBL] [Abstract][Full Text] [Related]
4. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.
Dutta SK; Campbell DL
Can J Comp Med; 1977 Oct; 41(4):404-8. PubMed ID: 200317
[TBL] [Abstract][Full Text] [Related]
5. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
6. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
Wilks CR; Coggins L
Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
[TBL] [Abstract][Full Text] [Related]
7. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
Eaglesome MD; Henry JN; McKnight JD
Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
[TBL] [Abstract][Full Text] [Related]
8. Cellular and antibody responses to equine herpesviruses 1 and 4.
Studdert MJ
J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
[No Abstract] [Full Text] [Related]
9. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
[TBL] [Abstract][Full Text] [Related]
10. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
Kydd JH; Townsend HG; Hannant D
Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
[TBL] [Abstract][Full Text] [Related]
11. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
12. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
Purdy CW; Porter RC; Ford SJ
Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
[No Abstract] [Full Text] [Related]
13. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
Bryans JT; Allen GP
Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
[TBL] [Abstract][Full Text] [Related]
14. Equine rhinopneumonitis vaccine: immunogenicity and safety in adult horses, including pregnant mares.
Purdy CW; Ford SJ; Porter RC
Am J Vet Res; 1978 Mar; 39(3):377-83. PubMed ID: 205144
[No Abstract] [Full Text] [Related]
15. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
Foote CE; Love DN; Gilkerson JR; Whalley JM
Vet Microbiol; 2002 Aug; 88(1):13-25. PubMed ID: 12119135
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM
Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959
[TBL] [Abstract][Full Text] [Related]
17. [Application of the passive hemagglutination test to the study of equine rhinopneumonitis. II. Serologic study in horses].
Berrios P; Ibarra L; Riquelme S
Rev Latinoam Microbiol; 1986; 28(4):339-43. PubMed ID: 3035677
[No Abstract] [Full Text] [Related]
18. Immunological correlates of vaccination and infection for equine herpesvirus 1.
Goodman LB; Wimer C; Dubovi EJ; Gold C; Wagner B
Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
[TBL] [Abstract][Full Text] [Related]
19. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
Bannai H; Nemoto M; Tsujimura K; Yamanaka T; Kokado H; Kondo T; Matsumura T
Vet Microbiol; 2018 Aug; 222():18-24. PubMed ID: 30080668
[TBL] [Abstract][Full Text] [Related]
20. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
